Expanding the reach of the p53 tumor suppressor network

Por Zambetti, G P
Publicado em 2014

Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.

Por Wang, Q, Zambetti, G P, Suttle, D P
Publicado em 1997

A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.

Por Zambetti, G P, Olson, D, Labow, M, Levine, A J
Publicado em 1992

Wild-type p53 binds to the TATA-binding protein and represses transcription.

Por Seto, E, Usheva, A, Zambetti, G P, Momand, J, Horikoshi, N, Weinmann, R, Levine, A J, Shenk, T
Publicado em 1992

Genetically defining the mechanism of Puma- and Bim-induced apoptosis

Por Garrison, S P, Phillips, D C, Jeffers, J R, Chipuk, J E, Parsons, M J, Rehg, J E, Opferman, J T, Green, D R, Zambetti, G P
Publicado em 2012

An identical, complex TP53 mutation arising independently in two unrelated families with diverse cancer profiles: the complexity of interpreting cancer risk in carriers

Por Pinto, E M, Ribeiro, R C, Li, J, Taja-Chayeb, L, Carrasco, L F, de Lourdes Peña-Torres, M, Vidal-Millán, S, Maldonado-Mtz, H, Dueñas-González, A, McGregor, L, Zambetti, G P
Publicado em 2012

Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation

Por Figueiredo, B C, Sandrini, R, Zambetti, G P, Pereira, R M, Cheng, C, Liu, W, Lacerda, L, Pianovski, M A, Michalkiewicz, E, Jenkins, J, Rodriguez‐Galindo, C, Mastellaro, M J, Vianna, S, Watanabe, F, Sandrini, F, Arram, S B I, Boffetta, P, Ribeiro, R C
Publicado em 2006